Global disease experts have embarked on a Sh1.2 billion collaborative research project to understand the impact of the deadly Rift Valley fever virus and its disease impact across the continent.
The experts, drawn from institutions in Kenya and Tanzania, will be undertaking the project that is expected to pave the way for the development of vaccines to combat the disease.